Logo image of NTES

NETEASE INC-ADR (NTES) Stock Fundamental Analysis

USA - NASDAQ:NTES - US64110W1027 - ADR

146.84 USD
-4.05 (-2.68%)
Last: 9/26/2025, 10:31:08 AM
Fundamental Rating

7

Overall NTES gets a fundamental rating of 7 out of 10. We evaluated NTES against 80 industry peers in the Entertainment industry. NTES scores excellent points on both the profitability and health parts. This is a solid base for a good stock. NTES is valued quite cheap, while showing a decent growth score. This is a good combination! These ratings could make NTES a good candidate for value and quality investing.


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

In the past year NTES was profitable.
In the past year NTES had a positive cash flow from operations.
In the past 5 years NTES has always been profitable.
Each year in the past 5 years NTES had a positive operating cash flow.
NTES Yearly Net Income VS EBIT VS OCF VS FCFNTES Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

1.2 Ratios

The Return On Assets of NTES (16.41%) is better than 93.75% of its industry peers.
NTES has a Return On Equity of 22.87%. This is amongst the best in the industry. NTES outperforms 91.25% of its industry peers.
The Return On Invested Capital of NTES (17.40%) is better than 95.00% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for NTES is significantly above the industry average of 9.25%.
The 3 year average ROIC (14.54%) for NTES is below the current ROIC(17.40%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 16.41%
ROE 22.87%
ROIC 17.4%
ROA(3y)14.25%
ROA(5y)12.44%
ROE(3y)21.5%
ROE(5y)19.37%
ROIC(3y)14.54%
ROIC(5y)13.18%
NTES Yearly ROA, ROE, ROICNTES Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

NTES has a better Profit Margin (31.19%) than 97.50% of its industry peers.
NTES's Profit Margin has declined in the last couple of years.
NTES's Operating Margin of 31.43% is amongst the best of the industry. NTES outperforms 98.75% of its industry peers.
NTES's Operating Margin has improved in the last couple of years.
NTES has a Gross Margin of 63.17%. This is in the better half of the industry: NTES outperforms 71.25% of its industry peers.
NTES's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 31.43%
PM (TTM) 31.19%
GM 63.17%
OM growth 3Y14.45%
OM growth 5Y3.83%
PM growth 3Y13.59%
PM growth 5Y-4.68%
GM growth 3Y5.24%
GM growth 5Y3.25%
NTES Yearly Profit, Operating, Gross MarginsNTES Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

8

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so NTES is creating value.
Compared to 1 year ago, NTES has less shares outstanding
NTES has less shares outstanding than it did 5 years ago.
NTES has a better debt/assets ratio than last year.
NTES Yearly Shares OutstandingNTES Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
NTES Yearly Total Debt VS Total AssetsNTES Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50B 100B 150B

2.2 Solvency

NTES has a debt to FCF ratio of 0.25. This is a very positive value and a sign of high solvency as it would only need 0.25 years to pay back of all of its debts.
With an excellent Debt to FCF ratio value of 0.25, NTES belongs to the best of the industry, outperforming 88.75% of the companies in the same industry.
A Debt/Equity ratio of 0.08 indicates that NTES is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.08, NTES is in the better half of the industry, outperforming 62.50% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF 0.25
Altman-Z N/A
ROIC/WACC2.54
WACC6.85%
NTES Yearly LT Debt VS Equity VS FCFNTES Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B 100B

2.3 Liquidity

NTES has a Current Ratio of 3.23. This indicates that NTES is financially healthy and has no problem in meeting its short term obligations.
NTES has a better Current ratio (3.23) than 90.00% of its industry peers.
A Quick Ratio of 3.22 indicates that NTES has no problem at all paying its short term obligations.
NTES has a Quick ratio of 3.22. This is amongst the best in the industry. NTES outperforms 90.00% of its industry peers.
Industry RankSector Rank
Current Ratio 3.23
Quick Ratio 3.22
NTES Yearly Current Assets VS Current LiabilitesNTES Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50B 100B 150B

5

3. Growth

3.1 Past

NTES shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 18.55%, which is quite good.
Measured over the past years, NTES shows a quite strong growth in Earnings Per Share. The EPS has been growing by 17.51% on average per year.
The Revenue has been growing slightly by 2.74% in the past year.
NTES shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 12.19% yearly.
EPS 1Y (TTM)18.55%
EPS 3Y21.03%
EPS 5Y17.51%
EPS Q2Q%22.9%
Revenue 1Y (TTM)2.74%
Revenue growth 3Y6.32%
Revenue growth 5Y12.19%
Sales Q2Q%9.44%

3.2 Future

The Earnings Per Share is expected to decrease by -26.15% on average over the next years. This is quite bad
The Revenue is expected to grow by 9.49% on average over the next years. This is quite good.
EPS Next Y21.23%
EPS Next 2Y13.42%
EPS Next 3Y12.44%
EPS Next 5Y-26.15%
Revenue Next Year8.55%
Revenue Next 2Y8.05%
Revenue Next 3Y8.17%
Revenue Next 5Y9.49%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
NTES Yearly Revenue VS EstimatesNTES Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 50B 100B 150B 200B
NTES Yearly EPS VS EstimatesNTES Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 20 40 60

7

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 17.71, NTES is valued on the expensive side.
Based on the Price/Earnings ratio, NTES is valued cheaply inside the industry as 86.25% of the companies are valued more expensively.
Compared to an average S&P500 Price/Earnings ratio of 27.06, NTES is valued a bit cheaper.
Based on the Price/Forward Earnings ratio of 15.68, the valuation of NTES can be described as correct.
Based on the Price/Forward Earnings ratio, NTES is valued cheaper than 87.50% of the companies in the same industry.
NTES's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 22.64.
Industry RankSector Rank
PE 17.71
Fwd PE 15.68
NTES Price Earnings VS Forward Price EarningsNTES Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

77.50% of the companies in the same industry are more expensive than NTES, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of NTES indicates a rather cheap valuation: NTES is cheaper than 90.00% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 15.23
EV/EBITDA 12.4
NTES Per share dataNTES EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
NTES has an outstanding profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as NTES's earnings are expected to grow with 12.44% in the coming years.
PEG (NY)0.83
PEG (5Y)1.01
EPS Next 2Y13.42%
EPS Next 3Y12.44%

5

5. Dividend

5.1 Amount

NTES has a Yearly Dividend Yield of 1.89%.
NTES's Dividend Yield is rather good when compared to the industry average which is at 20.19. NTES pays more dividend than 90.00% of the companies in the same industry.
Compared to the average S&P500 Dividend Yield of 2.38, NTES is paying slightly less dividend.
Industry RankSector Rank
Dividend Yield 1.89%

5.2 History

The dividend of NTES has a limited annual growth rate of 4.94%.
NTES has been paying a dividend for at least 10 years, so it has a reliable track record.
NTES has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)4.94%
Div Incr Years3
Div Non Decr Years3
NTES Yearly Dividends per shareNTES Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2

5.3 Sustainability

36.90% of the earnings are spent on dividend by NTES. This is a low number and sustainable payout ratio.
DP36.9%
EPS Next 2Y13.42%
EPS Next 3Y12.44%
NTES Yearly Income VS Free CF VS DividendNTES Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B
NTES Dividend Payout.NTES Dividend Payout, showing the Payout Ratio.NTES Dividend Payout.PayoutRetained Earnings

NETEASE INC-ADR

NASDAQ:NTES (9/26/2025, 10:31:08 AM)

146.84

-4.05 (-2.68%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)08-14 2025-08-14/bmo
Earnings (Next)11-12 2025-11-12/bmo
Inst Owners12.06%
Inst Owner Change-23.06%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap94.64B
Analysts82.22
Price Target157.54 (7.29%)
Short Float %1.68%
Short Ratio2.87
Dividend
Industry RankSector Rank
Dividend Yield 1.89%
Yearly Dividend2.45
Dividend Growth(5Y)4.94%
DP36.9%
Div Incr Years3
Div Non Decr Years3
Ex-Date08-28 2025-08-28 (0.57)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)10.07%
Min EPS beat(2)-2.68%
Max EPS beat(2)22.83%
EPS beat(4)2
Avg EPS beat(4)6.87%
Min EPS beat(4)-8.86%
Max EPS beat(4)22.83%
EPS beat(8)4
Avg EPS beat(8)4.89%
EPS beat(12)7
Avg EPS beat(12)13.23%
EPS beat(16)10
Avg EPS beat(16)14.05%
Revenue beat(2)0
Avg Revenue beat(2)-2.35%
Min Revenue beat(2)-3.91%
Max Revenue beat(2)-0.78%
Revenue beat(4)0
Avg Revenue beat(4)-3.07%
Min Revenue beat(4)-4.07%
Max Revenue beat(4)-0.78%
Revenue beat(8)0
Avg Revenue beat(8)-3.46%
Revenue beat(12)0
Avg Revenue beat(12)-3.33%
Revenue beat(16)2
Avg Revenue beat(16)-2.21%
PT rev (1m)6.37%
PT rev (3m)8.52%
EPS NQ rev (1m)0.28%
EPS NQ rev (3m)-0.15%
EPS NY rev (1m)0%
EPS NY rev (3m)1.07%
Revenue NQ rev (1m)0.57%
Revenue NQ rev (3m)0.69%
Revenue NY rev (1m)-0.09%
Revenue NY rev (3m)0.42%
Valuation
Industry RankSector Rank
PE 17.71
Fwd PE 15.68
P/S 6.15
P/FCF 15.23
P/OCF 14.48
P/B 4.51
P/tB 4.51
EV/EBITDA 12.4
EPS(TTM)8.29
EY5.65%
EPS(NY)9.37
Fwd EY6.38%
FCF(TTM)9.64
FCFY6.57%
OCF(TTM)10.14
OCFY6.91%
SpS23.89
BVpS32.58
TBVpS32.58
PEG (NY)0.83
PEG (5Y)1.01
Profitability
Industry RankSector Rank
ROA 16.41%
ROE 22.87%
ROCE 21.81%
ROIC 17.4%
ROICexc 130.14%
ROICexgc 130.14%
OM 31.43%
PM (TTM) 31.19%
GM 63.17%
FCFM 40.36%
ROA(3y)14.25%
ROA(5y)12.44%
ROE(3y)21.5%
ROE(5y)19.37%
ROIC(3y)14.54%
ROIC(5y)13.18%
ROICexc(3y)98.11%
ROICexc(5y)81.85%
ROICexgc(3y)117.55%
ROICexgc(5y)98.29%
ROCE(3y)19.38%
ROCE(5y)17.87%
ROICexcg growth 3Y31.39%
ROICexcg growth 5Y13.28%
ROICexc growth 3Y29.84%
ROICexc growth 5Y14.27%
OM growth 3Y14.45%
OM growth 5Y3.83%
PM growth 3Y13.59%
PM growth 5Y-4.68%
GM growth 3Y5.24%
GM growth 5Y3.25%
F-Score8
Asset Turnover0.53
Health
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF 0.25
Debt/EBITDA 0.31
Cap/Depr 107.66%
Cap/Sales 2.09%
Interest Coverage 97.92
Cash Conversion 127.21%
Profit Quality 129.41%
Current Ratio 3.23
Quick Ratio 3.22
Altman-Z N/A
F-Score8
WACC6.85%
ROIC/WACC2.54
Cap/Depr(3y)107.89%
Cap/Depr(5y)102.75%
Cap/Sales(3y)2.99%
Cap/Sales(5y)3.4%
Profit Quality(3y)118.33%
Profit Quality(5y)132.69%
High Growth Momentum
Growth
EPS 1Y (TTM)18.55%
EPS 3Y21.03%
EPS 5Y17.51%
EPS Q2Q%22.9%
EPS Next Y21.23%
EPS Next 2Y13.42%
EPS Next 3Y12.44%
EPS Next 5Y-26.15%
Revenue 1Y (TTM)2.74%
Revenue growth 3Y6.32%
Revenue growth 5Y12.19%
Sales Q2Q%9.44%
Revenue Next Year8.55%
Revenue Next 2Y8.05%
Revenue Next 3Y8.17%
Revenue Next 5Y9.49%
EBIT growth 1Y18.69%
EBIT growth 3Y21.69%
EBIT growth 5Y16.49%
EBIT Next Year36.95%
EBIT Next 3Y17.61%
EBIT Next 5Y16.14%
FCF growth 1Y65.97%
FCF growth 3Y19.76%
FCF growth 5Y21.96%
OCF growth 1Y54.29%
OCF growth 3Y16.76%
OCF growth 5Y18.17%